BRYNJELSEN SEAN
SEC CIK 1669976 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals, Inc. | Pres, CEO, Dir, 10% | 961.2K | $64.2K | $13.51M | 8 | 2021-08-20 | 2026-08-19 |
Most active insiders at ETON, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BRYNJELSEN SEAN | Pres, CEO, Dir, 10% | — | $9.91M |
| 2 | Opaleye Management Inc. | 10% | — | $6.89M |
| 3 | MAIER PAUL V | Dir | — | $5.91M |
| 4 | Krempa David | Chief Business Off | — | $4.86M |
| 5 | Adams Jennifer McKie | Dir | — | $1.62M |
| 6 | Erdogan-Trinkaus Ipek | Chief Commercial Off | — | — |
| 7 | Gruber James R. | CFO | — | — |
| 8 | RIEDEL NORBERT G | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-08-20 18:26 | 2026-08-19+ | ETON | Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | Pres, CEO, Dir | S - Sale | $60.88 | -100.0K | 961.2K | -9% | -$6.09M |
| DM | 2026-07-14 17:28 | 2026-07-12+ | ETON | Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | Pres, CEO, Dir | M - OptEx | $1.37 | +227.5K | 1.06M | +27% | +$311.7K |
| M | 2026-05-29 16:16 | 2026-05-28 | ETON | Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | Pres, CEO, Dir | S - Sale | $31.88 | -120.0K | 833.7K | -13% | -$3.83M |
| D | 2026-01-14 | 2026-01-01 | ETON | Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | Pres, CEO, Dir, 10% | F - Tax | $15.39 | -5,015 | 2.89M | -0.2% | -$77.2K |
| 2025-12-12 | 2025-12-12 | ETON | Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | Pres, CEO, Dir, 10% | F - Tax | $16.83 | -6,732 | 2.89M | -0.2% | -$113.3K | |
| M | 2025-06-05 | 2025-06-03+ | ETON | Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | Pres, CEO, Dir, 10% | S - Sale | $17.11 | -210.0K | 3.01M | -7% | -$3.59M |
| 2022-09-23 | 2022-09-22 | ETON | Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | CEO, Dir | P - Purchase | $2.10 | +10.0K | 1.04M | +1.0% | +$21.0K | |
| 2021-08-20 | 2021-08-20 | ETON | Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | Pres, CEO, Dir | P - Purchase | $4.32 | +10.0K | 1.03M | +1.0% | +$43.2K |
Purchase Sale Sale after option exercise All abbreviations